Basel Medical Group Ltd · NASDAQ:BMGL

Basel Medical Group Ltd financial statements

Basel Medical Group Ltd's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SGD

Income statement

LineFY2026FY2025FY2024FY2023FY2022
Revenue21.5M11.3M10.1M9.70M10.7M
Cost of revenue13.2M2.53M2.25M2.34M2.18M
Gross profit8.34M8.79M7.80M7.36M8.48M
Selling, general and administrative9.24M6.54M3.64M3.27M4.04M
Operating income8.33M-2.18M2.20M2.00M2.47M
Depreciation and amortization3.90M107.7K30.1K557.1K575.9K
EBITDA12.2M-2.08M2.23M2.56M3.05M
Interest expense460.0K203.9K176.2K238.6K320.9K
Income before tax-1.25M-11.1M2.40M2.13M2.39M
Income tax179.6K-417.4K331.8K348.3K408.5K
Net income-748.0K-10.6M2.07M1.78M1.98M
Earnings per share, basic-0.47-0.640.131.321.46
Earnings per share, diluted-0.570.13

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022
Cash and equivalents529.9K3.04M1.95M1.22M1.56M
Receivables10.3M9.49M2.01M13.3M13.9M
Inventory230.9K489.1K72.0K94.6K69.8K
Current assets12.1M13.3M16.2M14.8M15.7M
Property, plant and equipment388.7K34.5K
Goodwill10.3M
Total assets17.8M18.7M16.3M15.4M16.8M
Accounts payable3.55M6.57M2.58M1.46M1.08M
Current liabilities9.86M10.2M7.16M6.47M7.19M
Long-term debt2.96M1.58M3.40M5.31M
Total debt9.62M10.2M8.58M7.21M10.2M
Total liabilities13.3M13.2M8.75M9.89M13.1M
Shareholders' equity5.06M5.44M7.56M5.49M3.71M
Shares outstanding1.58M1.56M1.35M1.35M1.35M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022
Cash from operations-635.2K-4.04M2.51M2.60M2.79M
Capital spending-248.2K-556.9K-7.92K-6.16K-88.5K
Free cash flow-883.4K-4.60M2.50M2.59M2.70M
Cash from investing-104.2K-10.9M-7.92K-6.16K-88.5K
Cash from financing-1.78M16.5M-1.77M-2.94M-12.9M
Change in cash-2.51M1.56M733.6K-346.2K-10.2M